What is the ticker symbol for Liminal BioSciences?

Liminal BioSciences trades under the ticker LMNL on NASDAQ.

What sector does Liminal BioSciences operate in?

Liminal BioSciences is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze LMNL in a portfolio?

PortView shows LMNL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Liminal BioSciences (LMNL) Stock Analysis

NASDAQHealthcareBiotechnology

$8.50+0.12%

1-year price historyRange $3.25 – $8.50

52-week range$8.50

$3.10$8.50

What Liminal BioSciences does

Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.

Key metrics

Market cap

$27.62M

P/E (TTM)

-1.24

EPS (TTM)

$-6.83

Beta

1.03

Dividend yield

0.00%

Revenue / share

$4.74

50-day avg

$8.40

200-day avg

$6.20

52-week high

$8.50

52-week low

$3.10

CEO

Bruce Pritchard BA, CA, FIOD

ETFs linked to LMNL

Broad-market and Healthcare sector ETFs an investor holding Liminal BioSciences is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how LMNL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze LMNL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Liminal BioSciences?: Liminal BioSciences trades under the ticker LMNL on NASDAQ.
Which exchange is LMNL listed on?: LMNL is listed on NASDAQ.
What sector does Liminal BioSciences operate in?: Liminal BioSciences is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze LMNL in a portfolio?: PortView shows LMNL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.